Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Apr 30;296(6631):1217–1220. doi: 10.1136/bmj.296.6631.1217

Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical β adrenoceptor agonist

A A Connacher, R T Jung, P E G Mitchell
PMCID: PMC2545702  PMID: 2898268

Abstract

A double blind placebo controlled study was carried out in 40 subjects newly referred for treatment for obesity to determine the effects of the new thermogenic β adrenoceptor agonist BRL 26830A. The subjects were randomised to receive either BRL 26830A, 200 mg daily for two weeks then 400 mg daily, or placebo for 18 weeks, and all were instructed to follow a 3·35 MJ diet that was low in fat and high in fibre. Weight loss was 15·4 (SD 6·6) kg in subjects given BRL 26830A compared with 10·0 (5·9) kg in those given placebo (p=0·02). The relative weight loss was 0·93 (0·39)% a week with BRL 26830A and 0·61 (0·38)% with placebo (p=0·02). Urinary excretion of nitrogen was similar in both groups, whereas measurements of skinfold thickness indicated a 4·1 kg difference in the amount of fat lost, suggesting that weight loss with BRL 26830A was mainly from adipose and not lean tissue. BRL 26830A had no effect on resting pulse rate or pressor effects on either diastolic or systolic blood pressure. No significant differences were found between the two groups in serum cholesterol concentration, percentage of high density lipoprotein cholesterol, plasma concentrations of glucose and insulin, the ratio of glucose to insulin, serum concentrations of triiodothyronine and thyroxine, and creatinine clearance. Short term administration of BRL 26830A to six subjects who had taken the drug for 18 weeks showed that the expenditure of energy increased by 11·6% during the second hour after administration, which suggests that BRL 26830A may enhance weight loss thermogenically.

BRL 26830A may be a useful drug in the treatment of obesity.

Full text

PDF
1217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arch J. R., Ainsworth A. T., Cawthorne M. A., Piercy V., Sennitt M. V., Thody V. E., Wilson C., Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 1984 May 10;309(5964):163–165. doi: 10.1038/309163a0. [DOI] [PubMed] [Google Scholar]
  2. Arch J. R., Ainsworth A. T., Ellis R. D., Piercy V., Thody V. E., Thurlby P. L., Wilson C., Wilson S., Young P. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents. Int J Obes. 1984;8 (Suppl 1):1–11. [PubMed] [Google Scholar]
  3. Arch J. R., Ainsworth A. T. Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats. Am J Clin Nutr. 1983 Oct;38(4):549–558. doi: 10.1093/ajcn/38.4.549. [DOI] [PubMed] [Google Scholar]
  4. Astrup A., Lundsgaard C., Madsen J., Christensen N. J. Enhanced thermogenic responsiveness during chronic ephedrine treatment in man. Am J Clin Nutr. 1985 Jul;42(1):83–94. doi: 10.1093/ajcn/42.1.83. [DOI] [PubMed] [Google Scholar]
  5. Bray G. A., Melvin K. E., Chopra I. J. Effect of triiodothyronine on some metabolic responses of obese patients. Am J Clin Nutr. 1973 Jul;26(7):715–721. doi: 10.1093/ajcn/26.6.715. [DOI] [PubMed] [Google Scholar]
  6. Carroll M. J., Lister C. A., Sennitt M. V., Stewart-Long N., Cawthorne M. A. Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830. Diabetes. 1985 Nov;34(11):1198–1204. doi: 10.2337/diab.34.11.1198. [DOI] [PubMed] [Google Scholar]
  7. Cunningham S., Leslie P., Hopwood D., Illingworth P., Jung R. T., Nicholls D. G., Peden N., Rafael J., Rial E. The characterization and energetic potential of brown adipose tissue in man. Clin Sci (Lond) 1985 Sep;69(3):343–348. doi: 10.1042/cs0690343. [DOI] [PubMed] [Google Scholar]
  8. Danforth E., Jr, Horton E. S., O'Connell M., Sims E. A., Burger A. G., Ingbar S. H., Braverman L., Vagenakis A. G. Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest. 1979 Nov;64(5):1336–1347. doi: 10.1172/JCI109590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Durnin J. V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974 Jul;32(1):77–97. doi: 10.1079/bjn19740060. [DOI] [PubMed] [Google Scholar]
  10. Galloway S. M., Farquhar D. L., Munro J. F. The current status of antiobesity drugs. Postgrad Med J. 1984;60 (Suppl 3):19–26. [PubMed] [Google Scholar]
  11. Jung R. T., Shetty P. S., James W. P., Barrand M. A., Callingham B. A. Reduced thermogenesis in obesity. Nature. 1979 May 24;279(5711):322–323. doi: 10.1038/279322a0. [DOI] [PubMed] [Google Scholar]
  12. Jung R. T., Shetty P. S., James W. P. The effect of refeeding after semistarvation on catecholamine and thyroid metabolism. Int J Obes. 1980;4(2):95–100. [PubMed] [Google Scholar]
  13. Kyle L. H., Ball M. F., Doolan P. D. Effect of thyroid hormone on body composition in myxedema and obesity. N Engl J Med. 1966 Jul 7;275(1):12–17. doi: 10.1056/NEJM196607072750103. [DOI] [PubMed] [Google Scholar]
  14. Roberts I., Smith I. M. A simple method for the measurement of glycerol in serum. Ann Clin Biochem. 1986 Jul;23(Pt 4):490–491. doi: 10.1177/000456328602300418. [DOI] [PubMed] [Google Scholar]
  15. Stunkard A. J., Craighead L. W., O'Brien R. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet. 1980 Nov 15;2(8203):1045–1047. doi: 10.1016/s0140-6736(80)92272-2. [DOI] [PubMed] [Google Scholar]
  16. Thurlby P. L., Ellis R. D. Differences between the effects of noradrenaline and the beta-adrenoceptor agonist BRL 28410 in brown adipose tissue and hind limb of the anaesthetized rat. Can J Physiol Pharmacol. 1986 Aug;64(8):1111–1114. doi: 10.1139/y86-189. [DOI] [PubMed] [Google Scholar]
  17. WEIR J. B. DE B. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949 Aug;109(1-2):1–9. doi: 10.1113/jphysiol.1949.sp004363. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES